The post Investing in AI, health tech appeared on BitcoinEthereumNews.com. Giorgos Tsetis, cofounder and former CEO of Nutrafol. Courtesy of Great Things A versionThe post Investing in AI, health tech appeared on BitcoinEthereumNews.com. Giorgos Tsetis, cofounder and former CEO of Nutrafol. Courtesy of Great Things A version

Investing in AI, health tech

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

Giorgos Tsetis, cofounder and former CEO of Nutrafol.

Courtesy of Great Things

A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox.

After struggling with hair loss in his 20s, Giorgos Tsetis co-founded Nutrafol in 2014 to make supplements that address hair growth. Early this year, Tsetis sold his remaining equity at a valuation of $3.5 billion to Unilever and stepped down as Nutrafol’s CEO.

The 41-year-old told Inside Wealth he had two goals for his next chapter: to leave a better world for his young children and invest in companies with an eye toward social good.

“Early on, I had investors who made hundreds and hundreds of millions of dollars by essentially doing nothing. I just made wealthier people wealthier, and there’s nothing wrong with that,” he said in an interview. However, as a founder, he said he would have appreciated knowing that his success was also supporting causes like food access and mental health.

Six months ago, Tsetis launched his family office, Great Things, with the goal of using his investment profits to fund his philanthropy. He represents a growing class of ultra-wealthy millennials such as Walmart heir Lukas Walton who are setting up family offices early in life to promote causes like sustainability over sheer wealth preservation. And while many corporate asset managers have dialed back their impact investing, family offices largely haven’t, and next-generation principals are expected to double down on environmentally or socially conscious investing.

“I think the last thing you want to hand over to your children is wealth. I don’t necessarily think that is beneficial, even though we may think that that’s true,” Tsetis said. “I want to make impact now, and what I am excited about is to involve my children in those processes so they can see what’s happening in the world.”

Tsetis designed Great Things with a for-profit and a nonprofit arm, with the goal of using investment returns to fund charities that support causes like mental health and crisis response. Tsetis said a “significant portion” of the venture unit’s returns would go to philanthropy but declined to specify a percentage.

Tsetis began early-stage startup investing in earnest after Nutrafol’s Series B funding in 2019 and ramped it up after Unilever bought a majority stake in 2022. His portfolio includes artificial intelligence-driven companies focused on health care, like longevity startup NewLimit and BreakBio, a developer of personalized cancer vaccines.

His investment lens isn’t squarely focused on impact, having backed Anthropic, xAI and SpaceX. Tsetis acknowledged he has concerns about the ramifications of AI. “ChatGPT knows more about me than I know about myself, and that’s a problem,” he added. But Tsetis said early-stage investing makes it easier for him to get a seat at the table.

“You don’t know where the future is going to go,” he said. “I’d rather participate than be a spectator, and, wherever I can, drive and steer those conversations, because I do think that we need to prioritize human well-being.”

Tsetis’ ultimate goal is to give his portfolio companies a voice in how Great Things’ investment returns are donated.

Get Inside Wealth directly to your inbox

“Imagine if Nutrafol was able to deploy a million dollars at their choice,” he said. “That could have been quite interesting.”

Great Things has six full-time employees thus far, and Tsetis’s wife, Cerelina Proesl, advises on philanthropy. The family office has backed nonprofits including Every Cure, which uses artificial intelligence to identify existing drugs to treat rare diseases, and Ubuntu Pathways, a provider of education and HIV treatment in South Africa.

Tsetis said he hopes that other investors strategize on how to give back rather than doing so as an afterthought.

Social responsibility “should be something that people can get very excited about,” he said. “I’m hopeful that people want to do something about this problem that we currently experience, which is wealth concentration.”

Source: https://www.cnbc.com/2025/12/18/nutrafol-founder-giorgos-tsetis-philanthrophy.html

Market Opportunity
null Logo
null Price(null)
--
----
USD
null (null) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Tags:

You May Also Like

CME Group to Launch Solana and XRP Futures Options

CME Group to Launch Solana and XRP Futures Options

The post CME Group to Launch Solana and XRP Futures Options appeared on BitcoinEthereumNews.com. An announcement was made by CME Group, the largest derivatives exchanger worldwide, revealed that it would introduce options for Solana and XRP futures. It is the latest addition to CME crypto derivatives as institutions and retail investors increase their demand for Solana and XRP. CME Expands Crypto Offerings With Solana and XRP Options Launch According to a press release, the launch is scheduled for October 13, 2025, pending regulatory approval. The new products will allow traders to access options on Solana, Micro Solana, XRP, and Micro XRP futures. Expiries will be offered on business days on a monthly, and quarterly basis to provide more flexibility to market players. CME Group said the contracts are designed to meet demand from institutions, hedge funds, and active retail traders. According to Giovanni Vicioso, the launch reflects high liquidity in Solana and XRP futures. Vicioso is the Global Head of Cryptocurrency Products for the CME Group. He noted that the new contracts will provide additional tools for risk management and exposure strategies. Recently, CME XRP futures registered record open interest amid ETF approval optimism, reinforcing confidence in contract demand. Cumberland, one of the leading liquidity providers, welcomed the development and said it highlights the shift beyond Bitcoin and Ethereum. FalconX, another trading firm, added that rising digital asset treasuries are increasing the need for hedging tools on alternative tokens like Solana and XRP. High Record Trading Volumes Demand Solana and XRP Futures Solana futures and XRP continue to gain popularity since their launch earlier this year. According to CME official records, many have bought and sold more than 540,000 Solana futures contracts since March. A value that amounts to over $22 billion dollars. Solana contracts hit a record 9,000 contracts in August, worth $437 million. Open interest also set a record at 12,500 contracts.…
Share
BitcoinEthereumNews2025/09/18 01:39
XRP Accumulation Resumes as Buyers Take Advantage of Oversold Conditions

XRP Accumulation Resumes as Buyers Take Advantage of Oversold Conditions

The post XRP Accumulation Resumes as Buyers Take Advantage of Oversold Conditions appeared on BitcoinEthereumNews.com. XRP is quietly building energy, with buyers
Share
BitcoinEthereumNews2026/04/01 06:31
Trump melts down at judge who blocked his pet project

Trump melts down at judge who blocked his pet project

President Donald Trump lashed out at a federal judge who ordered that his administration halt construction on his signature ballroom and seek Congressional approval
Share
Rawstory2026/04/01 06:16